Vitamin C Deficiency Clinical Trial
Official title:
The Effect of Liposome Vitamin C on the Absorption
Verified date | May 2021 |
Source | TCI Co., Ltd. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To evaluate the difference between vitamin C in the form of oral liposomes and general vitamin C in a fixed period of time in plasma and urine.
Status | Completed |
Enrollment | 11 |
Est. completion date | December 31, 2020 |
Est. primary completion date | June 9, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 60 Years |
Eligibility | Inclusion Criteria: 1. Adults between 20-60 years old, 2. No heart, liver, kidney, endocrine and major organic diseases Exclusion Criteria: 1. Renal insufficiency and dialysis 2. Cancer 3. Underweight (BMI?17) or obese (BMI?27), 4. Take chronic disease drugs, 5. Blood pressure systolic blood pressure ?130 mmHg or diastolic blood pressure ?85 mmHg, 6. Too high fasting blood glucose ? 100 mg/dL, 7. Triglyceride ? 150 mg/dL,Total cholesterol ? 200 mg/dL, 8. Have a history of vitamin C allergy, 9. People with mental illness, 10. Pregnant or breastfeeding women, 11. Hematosis, 12. Kidney stones, 13. Long-term vitamin C supplements (at least 200 mg per day for more than one month) |
Country | Name | City | State |
---|---|---|---|
Taiwan | Research & Design Center, TCI CO., Ltd | Taipei |
Lead Sponsor | Collaborator |
---|---|
TCI Co., Ltd. |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | vitamin c detection | vitamin c was assessed by Ascorbic Acid Colorimetric Assay Kit II | at 8 hours after taking test sample | |
Primary | The change of Triglyceride | Venous blood was sampled to measure concentrations of Triglyceride | at 8 hours after taking test sample | |
Primary | The change of body mass index (BMI) | BMI is a measurement of a person's leanness or corpulence based on their height and weight, and is intended to quantify tissue mass.The body mass index (BMI, kg/m^2) and body mass (kg) were assessed by InBody770. | Time 0, 0.5, 1, 2, 3, 4, and 8 hours after taking test sample | |
Primary | The change of aspartate aminotransferase | Venous blood was sampled to measure concentrations of aspartate aminotransferase | at 8 hours after taking test sample | |
Primary | The change of alanine aminotransferase | Venous blood was sampled to measure concentrations of alanine aminotransferase | at 8 hours after taking test sample | |
Primary | The change of creatine | Venous blood was sampled to measure concentrations of creatine | at 8 hours after taking test sample |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03938584 -
The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients
|
N/A | |
Recruiting |
NCT02422901 -
A Long-term Study to Describe the Use of PASCORBIN® 7.5 g in Patients With Vitamin C Deficiency
|
||
Recruiting |
NCT05733078 -
Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism
|
Phase 2 | |
Completed |
NCT02606773 -
"Novo C Plus" Vitamin C Containing Dietary Supplement Bioavailability in Healthy Subjects
|
Phase 1 | |
Completed |
NCT00921622 -
Vitamin Deficiency and Blood Pressure in Hospitalized Jewish General Hospital (JGH) Patients
|
Phase 2 | |
Completed |
NCT03807791 -
Study of Prevalence and Risk Factors of Hypovitaminosis C in Long Term Care Unit
|
N/A | |
Not yet recruiting |
NCT03224572 -
The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT05009355 -
The Effect of Vitamin C on GCF Total Oxidant Capacity in Smoker Patients With Periodontitis
|
Early Phase 1 | |
Completed |
NCT04284696 -
Chewing Gum Containing Vitamin-c to Treat Emesis Gravidarum
|
N/A | |
Active, not recruiting |
NCT04337281 -
Evaluation of the Effect of High-dose Vitamin C Use in Covid 19 Positive Pregnants
|